Beijing publicized the first offer of the new crown drug: 750 yuan / box
Read Time:39 Second
On January 30, according to the Beijing Municipal Medical Security Bureau website, according to the requirements of the “Notice of the Office of the National Medical Security Bureau on the Issuance of “, the Beijing Municipal Medical Security Bureau has now publicized the first offer of Centrum Pharmaceuticals’ new crown therapeutic drug centronavir tablets/ritonavir tablets combination package Centrum. The reporter was informed that the first offer of cenotecan/ritonavir tablet combination is 750 RMB/box, and the ex-factory price including tax (or import CIF price) is 705-720 RMB/box. The initial offer was made against nematovir tablets/ritonavir tablets (Paxlovid), monoprevir capsules (Ridzoril), and Azulfidine tablets. In addition, the announcement disclosed API costs of $334.53 and direct R&D costs of $502,170,000.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating